Themba Moeti

6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial

Taraz Samandari, Tefera Agizew, Samba Nyirenda et al. · The Lancet · 2011 · 357 citations

Public Health, Pharmacotherapy, Preventive Medicine +12

Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Pharmacokinetics and Treatment Outcomes among a Predominantly HIV‐Infected Cohort of Adults with Tuberculosis from Botswana

Sekai Chideya, Carla A. Winston, Charles A. Peloquin et al. · Clinical Infectious Diseases · 2009 · 232 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Serum Concentrations of Antimycobacterial Drugs in Patients with Pulmonary Tuberculosis in Botswana

Jordan W. Tappero, Williamson Z. Bradford, Tracy Agerton et al. · Clinical Infectious Diseases · 2005 · 151 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Estimated HIV Trends and Program Effects in Botswana

John Stover, Boga Fidzani, Batho Chris Molomo et al. · PLoS ONE · 2008 · 77 citations · Full text

Public Health, Child Health, Infectious Disease Control +15

Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis

Mansour Farahani, Anusha M. Vable, Refeletswe Lebelonyane et al. · The Lancet Global Health · 2013 · 72 citations · Full text

Public Health, Health Sciences, Infectious Disease Control +13